Clobevate Cream (Clobetasol Propionate 0.05%) Portland — Potent Steroid for Eczema & Psoriasis | Oregon, USA (2026)
PRODUCT NAME
Brand Name: Clobevate Cream 0.05%
Generic Name: Clobetasol Propionate 0.05% w/w
Dosage Form: Topical Cream
Strength: 0.05%
Therapeutic Category: Super High-Potency Topical Corticosteroid
PRODUCT DETAILS
Clobevate Cream 0.05% contains Clobetasol Propionate, a super high-potency topical corticosteroid indicated for the short-term treatment of eczema, psoriasis, dermatitis, lichen planus, and other corticosteroid-responsive inflammatory skin disorders. It works by suppressing inflammatory mediators, reducing redness, itching, swelling, and skin irritation.
For patients in Portland, Oregon, Clobevate Cream is commonly prescribed when lower-potency topical corticosteroids have not provided sufficient symptom control. Due to its high potency, it should be applied as a thin layer to affected areas once or twice daily for the duration recommended by a healthcare professional. Treatment is generally limited to short courses to reduce the risk of skin thinning and systemic absorption. Avoid prolonged use on the face, groin, underarms, or under occlusive dressings unless specifically directed by a physician.
PRODUCT SPECIFICATION
| Brand Name | Clobevate Cream |
| Generic Name | Clobetasol Propionate |
| Strength | 0.05% w/w |
| Dosage Form | Topical Cream |
| Route of Administration | External Use Only |
| Drug Class | Super High-Potency Topical Corticosteroid |
| Active Ingredient | Clobetasol Propionate 0.05% |
| Indications | Eczema, Psoriasis, Dermatitis, Lichen Planus, Corticosteroid-Responsive Dermatoses |
| Application | Apply a thin layer once or twice daily as prescribed |
| Manufacturer | Glenmark Pharmaceuticals Ltd. |
| Storage | Store below 25°C in a cool, dry place, protected from moisture |
| Prescription Status | Prescription Medicine |
KEY FEATURES
- Contains Clobetasol Propionate 0.05%, one of the most potent topical corticosteroids.
- Provides rapid relief from itching, redness, inflammation, and swelling.
- Effective for severe eczema, plaque psoriasis, and resistant dermatitis.
- Helps reduce scaling, cracking, and skin discomfort.
- Cream formulation spreads easily and absorbs efficiently.
- Suitable for short-term treatment under medical supervision.
- May improve skin appearance by reducing inflammatory flare-ups.
- Manufactured under stringent pharmaceutical quality standards.
- Intended for external use only.
- Helps manage corticosteroid-responsive skin conditions when used appropriately.
INDUSTRY UPDATE
In 2026, dermatology guidelines in the United States continue to recommend Clobetasol Propionate 0.05% as a first-line option for short-term treatment of severe inflammatory skin diseases, including plaque psoriasis and acute eczema flares that do not respond adequately to lower-potency corticosteroids.
Current clinical practice emphasizes using the lowest effective dose for the shortest duration, along with regular emollient therapy and proactive skin barrier care to reduce recurrence and minimize corticosteroid-related adverse effects.
There is also growing emphasis on individualized treatment plans that combine topical corticosteroids with steroid-sparing therapies when appropriate for long-term disease management.
Portland's OHSU (Oregon Health & Science University), Providence Health, and Legacy Emanuel Medical Center serve Oregon's most populous city — whose progressive politics, outdoor culture, and significant houseless population create a distinctive eczema and psoriasis treatment landscape. Portland's Pacific Northwest climate (frequent rain, low humidity in summer, mild temperatures) creates specific skin conditions. Clobevate Cream provides Portland's eczema and psoriasis patients with affordable prescription-strength Clobetasol at dramatically reduced cost versus Oregon pharmacy pricing.
Visit unnatipharmax.com | 📱 +91 82650 41513 | 📧 Unnatipharmax@gmail.com
FAQ 1: How does Portland's famous outdoor culture — hiking, cycling, river activities — interact with eczema and Clobevate Cream use?
Portland's outdoor identity — Forest Park (the largest urban forest in the US), the Willamette River kayaking culture, Mount Hood skiing, and the Columbia River Gorge hiking — creates an active lifestyle that eczema significantly compromises. Eczema and Portland's outdoor activities: the two primary outdoor eczema triggers in Portland's environment are contact allergens (plant contact dermatitis from Pacific Northwest vegetation including poison oak, which is abundant in Forest Park and Columbia Gorge trails) and sweat-induced eczema exacerbation (sweat is a significant atopic eczema trigger — the breakdown products of eccrine sweat, including lactic acid and urocanic acid, directly trigger itch and inflammatory responses in eczema-prone skin). Clobevate Cream for Portland's flare management: during active eczema flares triggered by outdoor activity or contact allergens, Clobetasol 0.05% (Clobevate Cream) provides rapid, potent anti-inflammatory action — reducing erythema, oedema, and pruritus within 24-48 hours. The pulse therapy approach for Portland's active outdoor community: OHSU dermatology uses pulse Clobevate therapy for Portland eczema patients — short bursts (3-7 days) of Clobetasol during flares triggered by specific outdoor activities, rather than continuous application; this preserves Clobetasol's potency for flare management while avoiding the HPA axis suppression and skin atrophy that continuous potent topical steroid use causes. Psoriasis in Portland's outdoor community: psoriasis often improves with moderate natural UVB exposure (the Koebner phenomenon reversed by phototherapy); Portland's outdoor activities in summer provide natural phototherapy for some psoriasis-affected Portland residents; Clobevate Cream manages breakthrough flares during weather transitions, winter when natural UVB is minimal, and stress-triggered exacerbations common in Portland's dynamic urban environment.
FAQ 2: How does Portland's progressive social culture — including significant unhoused population — create specific eczema care equity concerns?
Portland has one of America's highest per-capita unhoused populations — approximately 5,000+ individuals experiencing homelessness on any given night, concentrated in Old Town Chinatown, the Burnside Bridge area, and encampments throughout the city. Eczema and homelessness in Portland: atopic eczema is dramatically worsened by homelessness — inability to maintain skin cleanliness from limited water access; exposure to environmental irritants (sleeping on concrete, synthetic fibre donations, contact with soil and mould); stress from housing insecurity directly triggering eczema flares through cortisol and sympathetic nervous system pathways; poor nutrition (vitamin D, zinc, and omega-3 deficiency from limited food access) compromising skin barrier function. Clobevate Cream in Portland's unhoused community: the inability to store medications safely (no refrigeration, theft risk in encampments, loss during sweeps) creates a practical challenge for any topical medication including Clobevate; Oregon Health Plan (OHP, Oregon's Medicaid) covers Clobetasol for eligible Oregon residents including those experiencing homelessness — Oregon's Medicaid eligibility is among America's most inclusive. The equity dimension: Portland's progressive public health community at OHSU has developed street medicine programmes that include dermatology outreach — providing eczema assessment and medication supply directly in Portland's encampments. For the working-poor Portland population above OHP income threshold but without employer insurance — concentrated in Portland's gig economy of food delivery and ride-sharing — Clobevate Cream from Unnati Pharmax at dramatically reduced cost addresses the prescriptions that Oregon pharmacy private pricing makes unaffordable for this population segment.
FAQ 3: What is Oregon's coverage landscape for Clobevate Cream and how does OHSU dermatology navigate the steroid step-care pathway?
Oregon Health Plan (OHP) — one of America's most comprehensive Medicaid programmes, with the Oregon Health Authority's innovative global budgeting approach — covers topical corticosteroids including Clobetasol (Clobevate equivalent) for eczema and psoriasis. OHSU's eczema step-care pathway for Oregon patients: Mild eczema — low-potency topical steroids (hydrocortisone 1%, desonide) for facial and flexural areas; Moderate eczema — mid-potency steroids (triamcinolone 0.1%, betamethasone valerate 0.1%) for trunk and extremities; Severe/refractory eczema — Clobevate Cream (Clobetasol 0.05%) for resistant plaques on non-facial, non-flexural areas; steroid-sparing agents — tacrolimus (Protopic) and pimecrolimus (Elidel) for facial and flexural sites where steroid atrophy is a concern; biologics (Dupilumab, Tralokinumab) for severe atopic dermatitis refractory to all topicals. Clobevate's position in this pathway: Clobevate Cream is used for the burst-therapy management of severe eczema flares at OHSU — applied for 7-14 days maximum, then stepped down to mid-potency steroid for maintenance; OHP covers Clobetasol on the Oregon formulary without prior authorisation for eczema and psoriasis; OHSU's pharmacy provides OHP-covered Clobetasol at negligible cost for enrolled patients. Clobevate from Unnati Pharmax serves Oregon patients in the OHP enrollment gap, for those above OHP income threshold without adequate private coverage, and for Portland's significant non-resident patient community visiting for OHSU specialist consultations from rural Oregon.
FAQ 4: How does Portland's cannabis culture intersect with eczema and Clobevate Cream use?
Oregon legalised recreational cannabis in 2015, and Portland has North America's most concentrated dispensary landscape — over 400 licensed dispensaries in Portland alone. The cannabis-eczema intersection is clinically relevant for Portland's Clobevate Cream users. Topical cannabidiol (CBD) for eczema: a significant proportion of Portland's eczema population uses topical CBD products (widely available at Portland dispensaries and natural food stores) as adjuncts to conventional treatment; evidence for topical CBD in eczema is limited but emerging — the skin's endocannabinoid system (CB1 and CB2 receptors in keratinocytes and immune cells) influences inflammatory responses and barrier function; topical CBD may provide modest anti-pruritic and anti-inflammatory benefit for mild eczema. CBD and Clobevate concurrent use: no pharmacokinetic interaction between topical CBD and Clobetasol has been established; using topical CBD as a pruritus-soothing adjunct between Clobevate Cream pulse courses is reasonable for Portland's cannabis-comfortable patient population; however, topical CBD should not replace Clobevate during active severe flares — CBD's efficacy is insufficient for controlling acute inflammatory eczema eruptions. Smoked/inhaled cannabis and eczema: the relationship is complex — cannabis smoke contains PAHs (polycyclic aromatic hydrocarbons) that can worsen atopic skin barrier; and the anti-anxiety effect of inhaled cannabis may indirectly benefit Portland's stress-triggered eczema population. OHSU dermatology's approach: Portland's OHSU dermatologists engage the cannabis-eczema conversation non-judgementally — recognising Portland's cannabis-normalised culture — while maintaining that Clobevate Cream remains the evidence-based standard for severe eczema flare management regardless of adjunctive cannabis choices.
FAQ 5: What are the essential safety guidelines for Clobevate Cream use that Portland's OHSU dermatology emphasises?
Clobetasol Propionate 0.05% (Clobevate Cream) is the most potent class of topical corticosteroid available — Class I (superpotent) by US classification. OHSU Portland's critical safety guidelines reflect this potency. Quantity and duration limits: maximum 50g per week; maximum 2 weeks continuous use without medical review; never exceed 3 months total use in any 12-month period to avoid HPA axis suppression and skin atrophy. Area restrictions — never apply Clobevate to: face (even briefly — facial skin is thin and absorbs corticosteroids at 3x the rate of body skin); axilla (armpit); groin and genitalia; under occlusive dressings unless specifically directed by a dermatologist (occlusion increases absorption 10-fold). Skin atrophy prevention: Clobevate causes irreversible skin atrophy (thinning, telangiectasia, striae) with extended use — Portland's OHSU dermatology uses the "four-S" reminder for patients: Strong (Clobevate is very strong), Short (use for short periods only), Specific (specific body areas, not widespread), and Stop (when the flare is controlled, stop and switch to milder steroid). HPA axis suppression risk: clinically significant HPA axis suppression occurs with large area application (above 50g/week) or prolonged use; symptoms — fatigue, weakness, weight change — should prompt immediate OHSU dermatology review. Portland's self-medication context: OHSU specifically addresses self-medication in Portland's health-literate, internet-research-oriented population; purchasing Clobevate Cream from Unnati Pharmax requires prior physician prescription precisely because self-directed superpotent steroid use without dermatological guidance risks all of the above complications; Unnati Pharmax does not supply Clobevate without prescription documentation for exactly these safety reasons.
Website
Email Id
Contact Number
+91-8265041513
Clobevate-Cream-Clobetasol-Propionate-0.05-Portland
